Newman James W. Jr. 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Jan 28, 2021
Insider Transaction Report
Form 4
Newman James W. Jr.
Director
Transactions
- Award
Common Stock
2021-01-26+1,187→ 14,475 total(indirect: By Partnership) - Award
Common Stock
2021-01-26+2,544→ 152,963 total(indirect: By LLC)
Holdings
- 15,000
Common Stock
- 35,221(indirect: By LLC)
Common Stock
- 41,160(indirect: By Trust)
Common Stock
- 14,644(indirect: By IRA)
Common Stock
Footnotes (6)
- [F1]The reporting person acquired an aggregate of 3,731 shares of issuer common stock in exchange for an aggregate 0.53% interest in Purnovate, LLC ("Purnovate") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and 70% of the shares are subject to forfeiture during a one year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement.
- [F2]James W. Newman is the general partner of Roundtop Limited Partnership, LLP.
- [F3]James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr.
- [F4]James W. Newman is the sole member of Virga Ventures, LLC.
- [F5]James W. Newman is the general partner of Ivy Cottage Group, LLC.
- [F6]James W. Newman is the beneficiary of this Roth IRA.